SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-045810
Filing Date
2024-11-08
Accepted
2024-11-08 15:15:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20038337_sc13g.htm SC 13G 68270
  Complete submission text file 0001140361-24-045810.txt   69946
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91363 | Film No.: 241440111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

IRS No.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SC 13G